Researcher
Anna Sablina
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Cell death, Cancer biology
- Disciplines (KU Leuven):Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
- See also: Anna Sablina (Flanders Institute for Biotechnology)
Affiliations
- Laboratory for Mechanisms of Cell Transformation (VIB-KU Leuven) (Division)
Responsible
From1 Jan 2017 → Today - Laboratory for Mechanisms of Cell Transformation (VIB-KU Leuven) (Division)
Member
From1 Jan 2017 → Today - Sablina Lab (Research group)
Responsible
From1 Jan 2017 → Today - Department of Human Genetics (Department)
Member
From16 Apr 2009 → 31 Dec 2016
Projects
1 - 10 of 20
- Molecular structure and pharmacological activation of LZTR1 towards novel anticancer therapiesFrom20 Aug 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Mapping the functional role of the low copy repeats in the phenotypic variability of the 22q11.2 Deletion SyndromeFrom27 Jan 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Optimize single -cell sequence approaches in PDACFrom14 Nov 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Micropeptides as novel biomarkers and precision medicine targets in cancerFrom26 Sep 2022 → 26 Jan 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Micropeptides in head and neck cancerFrom9 Nov 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Targeting KRAS proteoastasis to develop personalized therapies for lung cancer patientsFrom1 Oct 2021 → TodayFunding: Foundations, funds and other with scientific goal
- Micropeptides as potential targets for cancer treatment in Lung AdenocarcinomaFrom18 Nov 2020 → 1 Jun 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- The role of LZTR1 in cancer development and progressionFrom10 Apr 2020 → 10 Apr 2024Funding: Own budget, for example: patrimony, inscription fees, gifts
- Alterations in RAS interactome triggered by ubiquitinationFrom1 Dec 2019 → 1 Dec 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Nanobody-based approach to inhibit RAS activity by modultating its interactomeFrom1 Jan 2019 → 31 Dec 2022Funding: Foundations, funds and other with scientific goal
Publications
21 - 30 of 50
- The Mystery of Rap1 Suppression of Oncogenic Ras(2020)
Authors: Anna Sablina
Pages: 369 - 379 - Stress-induced lncRNA LASTR fosters cancer cell fitness by regulating the activity of the U4/U6 recycling factor SART3(2020)
Authors: Linde De Troyer, Maria Francesca Baietti, Jasmine Barra, Roberto Vendramin, Rüveyda Dok, Paul Najm, Anna Sablina
Pages: 2502 - 2517 - Co-regulation of the antagonistic RepoMan:Aurora-B pair in proliferating cells(2020)
Authors: Maria Giulia Manzione, Jan Rombouts, Anna Sablina, Lendert Gelens, Junbin Qian, Mathieu Bollen
Pages: 419 - 438 - The sixth international RASopathies symposium: Precision medicine-From promise to practice(2020)
Authors: Anna Sablina
Pages: 597 - 606 - Radiosensitization approaches for HPV-positive and HPV-negative head and neck squamous carcinomas(2020)
Authors: Rüveyda Dok, Marieke Bamps, Mary Glorieux, Anna Sablina, Sandra Nuyts
Pages: 1075 - 1085 - Mutations in LZTR1 drive human disease by dysregulating RAS ubiquitination(2018)
Authors: Silvia Pandolfi, Maria Francesca Baietti, Paolo Carai, Paul Najm, Fabrizio Renzi, Layka Abbasi Asbagh, Michal Simicek, Hilde Brems, Eric Legius, Ludwine Messiaen, et al.
Pages: 1177 - 1182 - Loss of protein phosphatase 2A regulatory subunit B56δ promotes spontaneous tumorigenesis in vivo(2018)
Authors: Caroline Lambrecht, Louis Libbrecht, Xavier Sagaert, Yana Hoorne, Jonathan Crowther, Ward Sents, Anna Sablina, Veerle Janssens
Pages: 544 - 552 - PP2A inactivation mediated by PPP2R4 haploinsufficiency promotes cancer development(2017)
Authors: Ward Sents, Bob Meeusen, Peter Kalev, Xavier Sagaert, Dorien Haesen, Caroline Lambrecht, Mieke Dewerchin, Peter Carmeliet, Anna Sablina, Veerle Janssens
Pages: 6825 - 6837 - Recurrent PPP2R1A mutations in uterine cancer act through a dominant-negative mechanism to promote malignant cell growth(2016)
Authors: Dorien Haesen, Layka Abbasi Asbagh, Rita Derua, Antoine Hubert, Frédéric Amant, Etienne Waelkens, Anna Sablina, Veerle Janssens
Pages: 5719 - 5731 - p53 induces formation of NEAT1 lncRNA-containing paraspeckles that modulate replication stress response and chemosensitivity(2016)
Authors: Carmen Adriaens, Jasmine Barra, Annelien Verfaillie, Bram Boeckx, Eleonora Leucci, Joost van den Oord, Anna Sablina, Diether Lambrechts, Stein Aerts, Chris Marine
Pages: 861 - 8